Nicholas James
0000-0002-7314-8204
Kyoto University
4 papers found
Refreshing results…
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer
Integrated Care in Prostate Cancer (ICARE-P): Nonrandomized Controlled Feasibility Study of Online Holistic Needs Assessment, Linking the Patient and the Health Care Team
Missing publications? Search for publications with a matching author name.